High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission

被引:2
|
作者
Agarwal, Arnav [1 ]
Basmaji, John [2 ]
Muttalib, Fiona [3 ]
Granton, David [4 ]
Chaudhuri, Dipayan [5 ]
Chetan, Devin [6 ,7 ]
Hu, Malini [4 ]
Fernando, Shannon M. [8 ,9 ]
Honarmand, Kimia [2 ,10 ]
Bakaa, Layla [11 ]
Brar, Sonia [12 ]
Rochwerg, Bram [5 ,13 ,14 ]
Adhikari, Neill K. [15 ,16 ]
Lamontagne, Francois [17 ,18 ]
Murthy, Srinivas [19 ]
Hui, David S. C. [20 ,21 ]
Gomersall, Charles [22 ]
Mubareka, Samira [23 ,24 ]
Diaz, Janet V. [25 ,26 ]
Burns, Karen E. A. [27 ,28 ,29 ]
Couban, Rachel [14 ,30 ]
Ibrahim, Quazi [14 ]
Guyatt, Gordon H. [14 ]
Vandvik, Per O. [31 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] Western Univ, Schulich Sch Med & Dent, Dept Med, Div Crit Care, London, ON, Canada
[3] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada
[4] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[5] McMaster Univ, Dept Med, Hamilton, ON, Canada
[6] Univ Toronto, Dept Pediat, Toronto, ON, Canada
[7] Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, Toronto, ON, Canada
[8] Univ Ottawa, Dept Med, Div Crit Care, Ottawa, ON, Canada
[9] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada
[10] Western Univ, Dept Med, Schulich Sch Med & Dent, London, ON, Canada
[11] McMaster Univ, Fac Sci, Honours Life Sci Program, Hamilton, ON, Canada
[12] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA
[13] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[14] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[15] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada
[16] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada
[17] Univ Sherbrooke, Sherbrooke, PQ, Canada
[18] CHU Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada
[19] Univ British Columbia, BC Childrens Hosp, Vancouver, BC, Canada
[20] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[21] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Hong Kong, Peoples R China
[22] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Peoples R China
[23] Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON, Canada
[24] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[25] Pacific Med Ctr, San Francisco, CA USA
[26] WHO, Geneva, Switzerland
[27] St Michaels Hosp, Unity Hlth Toronto, Toronto, ON, Canada
[28] Univ Toronto, Toronto, ON, Canada
[29] Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[30] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada
[31] MAGIC Evidence Ecosyst Fdn, Oslo, Norway
关键词
respiratory failure; COVID-19; SARS-CoV-2; high-flow nasal cannula; aerosols; CONVENTIONAL OXYGEN-THERAPY; POSITIVE-PRESSURE VENTILATION; RANDOMIZED CONTROLLED-TRIAL; NONINVASIVE VENTILATION; ENDOTRACHEAL INTUBATION; MECHANICAL VENTILATION; EMERGENCY-DEPARTMENT; AIRWAY PRESSURE; ADULT PATIENTS; INFLUENZA;
D O I
10.1007/s12630-020-01740-2
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose We conducted two World Health Organization-commissioned reviews to inform use of high-flow nasal cannula (HFNC) in patients with coronavirus disease (COVID-19). We synthesized the evidence regarding efficacy and safety (review 1), as well as risks of droplet dispersion, aerosol generation, and associated transmission (review 2) of viral products. Source Literature searches were performed in Ovid MEDLINE, Embase, Web of Science, Chinese databases, and medRxiv.Review 1: we synthesized results from randomized-controlled trials (RCTs) comparing HFNC to conventional oxygen therapy (COT) in critically ill patients with acute hypoxemic respiratory failure.Review 2:we narratively summarized findings from studies evaluating droplet dispersion, aerosol generation, or infection transmission associated with HFNC. For both reviews, paired reviewers independently conducted screening, data extraction, and risk of bias assessment. We evaluated certainty of evidence using GRADE methodology. Principal findings No eligible studies included COVID-19 patients.Review 1:12 RCTs (n= 1,989 patients) provided low-certainty evidence that HFNC may reduce invasive ventilation (relative risk [RR], 0.85; 95% confidence interval [CI], 0.74 to 0.99) and escalation of oxygen therapy (RR, 0.71; 95% CI, 0.51 to 0.98) in patients with respiratory failure. Results provided no support for differences in mortality (moderate certainty), or in-hospital or intensive care length of stay (moderate and low certainty, respectively).Review 2: four studies evaluating droplet dispersion and three evaluating aerosol generation and dispersion provided very low certainty evidence. Two simulation studies and a crossover study showed mixed findings regarding the effect of HFNC on droplet dispersion. Although two simulation studies reported no associated increase in aerosol dispersion, one reported that higher flow rates were associated with increased regions of aerosol density. Conclusions High-flow nasal cannula may reduce the need for invasive ventilation and escalation of therapy compared with COT in COVID-19 patients with acute hypoxemic respiratory failure. This benefit must be balanced against the unknown risk of airborne transmission.
引用
收藏
页码:1217 / 1248
页数:32
相关论文
共 50 条
  • [1] High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19
    Palacios Chavarria, Adrian
    Salinas Lezama, Erika
    Gonzalez Navarro, Mauricio
    Valdez Vazquez, Rafael Ricardo
    Herrera Bello, Hector
    Lomelin Gascon, Julieta
    Morales Juarez, Linda
    Arboleya Avendano, Monica
    Ramirez Gonzalez, Luis Esteban
    Ville Benavides, Rodrigo
    Alvarez Wyssmann, Renate Victoria
    Sandoval Ortiz, Brenda
    Rodriguez de la Cerda, Mariana Lizbeth
    Moreno Castaneda, Lidia
    Alberto Martinez-Juarez, Luis
    Gallardo-Rincon, Hector
    Tapia-Conyer, Roberto
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [2] High-Flow Nasal Cannula and Standard Oxygen in Acute Hypoxemic Respiratory Failure Due to COVID-19
    Gallardo, Adrian
    Devoli, Adrian P.
    Arevalo, German E. M. Bustillo
    Saavedra, Santiago N.
    Moracci, Roque S.
    Pratto, Romina A.
    Plotnikow, Gustavo A.
    Leone, Jose L.
    Travetto, Carolina M.
    [J]. RESPIRATORY CARE, 2022, 67 (12) : 1534 - 1541
  • [3] High-Flow nasal cannula treatment in patients with COVID-19 acute hypoxemic respiratory failure: A prospective cohort study
    Alshahrani, Mohammed S.
    Alshaqaq, Hassan M.
    Alhumaid, Jehan
    Binammar, Ammar A.
    AlSalem, Khalid H.
    Alghamdi, Abdulazez
    Abdulhady, Ahmed
    Yehia, Moamen
    AlSulaibikh, Amal
    Al Jumaan, Mohammed
    Albuli, Waleed H.
    Ibrahim, Talal
    Yousef, Abdullah A.
    Almubarak, Yousef
    Alhazzani, Waleed
    [J]. SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2021, 9 (03): : 215 - +
  • [4] Use of Inhaled Epoprostenol Delivered by High-Flow Nasal Cannula in Patients with Severe Acute Hypoxemic Respiratory Failure Secondary to COVID-19
    Sharma, N.
    Bhagat, M. K.
    Dudney, T. M.
    Dhand, R.
    Bevill, B. T.
    Branca, P. R.
    McCormack, M. T.
    Heidel, R. E.
    Green, J. W.
    Soto, F. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [5] Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19
    Garner, Orlando
    Dongarwar, Deepa
    Salihu, Hamisu M.
    Perez, Jairo H. Barrantes
    Abraham, Jocelyn
    McBride, Cameron
    Mathew, Sindhu
    Antony, Preethi
    Collins, Keegan
    Richards, Katherine L.
    Howard, Christopher M.
    [J]. RESPIRATORY MEDICINE, 2021, 185
  • [6] USE OF HIGH-FLOW NASAL CANNULA IN HYPOXEMIC RESPIRATORY FAILURE: A SYSTEMATIC REVIEW
    Lee, Chi Chan
    Mankodi, Dhruti
    Shaharyar, Sameer
    Ravindranathan, Sharmila
    Danckers, Mauricio
    Herscovici, Pablo
    Ferrer, Gustavo
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [7] High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
    Frat, Jean-Pierre
    Thille, Arnaud W.
    Mercat, Alain
    Girault, Christophe
    Ragot, Stephanie
    Perbet, Sebastien
    Prat, Gwenael
    Boulain, Thierry
    Morawiec, Elise
    Cottereau, Alice
    Devaquet, Jerome
    Nseir, Saad
    Razazi, Keyvan
    Mira, Jean-Paul
    Argaud, Laurent
    Chakarian, Jean-Charles
    Ricard, Jean-Damien
    Wittebole, Xavier
    Chevalier, Stephanie
    Herbland, Alexandre
    Fartoukh, Muriel
    Constantin, Jean-Michel
    Tonnelier, Jean-Marie
    Pierrot, Marc
    Mathonnet, Armelle
    Beduneau, Gaetan
    Deletage-Metreau, Celine
    Richard, Jean-Christophe M.
    Brochard, Laurent
    Robert, Rene
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (23): : 2185 - 2196
  • [8] Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure
    Mauri, Tommaso
    Turrini, Cecilia
    Eronia, Nilde
    Grasselli, Giacomo
    Volta, Carlo Alberto
    Bellani, Giacomo
    Pesenti, Antonio
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1207 - 1215
  • [10] Comparison of High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure Due to Severe COVID-19 Pneumonia
    Nair, Parvathy Ramachandran
    Haritha, Damarla
    Behera, Srikant
    Kayina, Choro Athiphro
    Maitra, Souvik
    Anand, Rahul Kumar
    Ray, Bikash Ranjan
    Soneja, Manish
    Subramaniam, Rajeshwari
    Baidya, Dalim Kumar
    [J]. RESPIRATORY CARE, 2021, 66 (12) : 1824 - 1830